|Name||Hilton Zurich Airport Hotel|
|Stadt||8152 Zürich, Schweiz|
Plenary Discussion Sessions include:
• Public Markets and M&A
• Investment (2 sessions on Early & Late Stage)
• MedTech & Diagnostics
• Specific Therapeutic Panels on:â€‹
– Autoimmune & Inflammatory
– Oncology (2 sessions)
– Platform Technologies & Novel Therapeutics
We expect around 350 delegates and 80 presenting companies. With over half confirmed already, we suggest that you reserve your place and take advantage of the registration promotion of 10% off the registration fee.
To enquire about attending, presenting or exhibiting please fill in our online form and one of our team members will be in touch with you shortly.
Confirmed Speakers & Chairs include:
Adam Kostyàl, Senior Vice President, NASDAQ OMX
Ajan Reginald, Chief Executive Officer, Cell Therapy Ltd.
Anja König, Managing Director, Novartis Venture Fund
Anker Lundemose, CEO, MISSION Therapeutics Ltd.
Beat Merz, Managing Director, Rockport Venture Partners
Boris Zaïtra, Head of Corporate M&A, F. Hoffmann-La Roche Ltd.
Chandra Leo, Portfolio Manager, HBM Partners AG
• To view the full list of speakers already confirmed please click HERE
Attendees will receive:
• Access to our online 1-2-1 meeting system with publication of your profile
• Access to all workshops, presentations and panel discussions
• Company listing on the event website
• Networking lunch, coffee breaks and reception during the conference
If you have any questions or require any additional information about the event please contact The Sachs Associates Team.